Thank you for sharing!
Indeed! The FDA`s long-awaited guidance on "Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products" will be a game-changer for biostatistics and drug development! It should and will open doors to smarter, more efficient trials.
The success of adopting Bayesian methodology will depend on educational measures during graduate and postgraduate studies to build foundational expertise, along with other key factors such as regulatory clarity and acceptance, accessible software and computational tools, overcoming traditional frequentist biases, and strong collaboration among statisticians, clinicians, and regulators.
Can't wait to dive deeper and see how it accelerates innovation. What are your thoughts,
@f2harrell?
#FDA #BayesianStats #ClinicalTrials